Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta-analysis.

저자: Yanhua Li, Chunmei Lv, Lianlian Cao, Sun Lihua, Yanqu Ma
저널: Biomedical reports
공개일: 2026 Aug
연구 유형: 기타
DOI: 10.3892/br.2026.2165

문헌 요약

Semaglutide, a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA), has been associated with cardiovascular benefits, whereas the consistency of its effect across various clinical settings, as well as its safety-economic profile, remains uncertain. MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, Clini…

PV 검토 포인트

개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.

PubMed에서 원문 정보 보기 ↗